Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127258) titled 'Impacts of Neoadjuvant therapy on Survival and Recurrence Patterns in High-Risk Resectable Intrahepatic Cholangiocarcinoma: A propensity Score Analysis' on June 28.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Sun Yat-sen Memorial Hospital

Condition: Intrahepatic cholangiocarcinoma

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-06-29

Target Sample Size: Observation group:250;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=330094

Published by HT Digital Content Services with permission from H...